Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

17

Oct 2019

Mycovia Pharmaceuticals Announces Partnership with Gedeon Richter to Commercialize and Manufacture VT-1161 for Recurrent Vulvovaginal Candidiasis

Mycovia Pharmaceuticals Inc today announced it has entered into an exclusive license and development and technology transfer agreement with Gedeon Richter Plc based in Budapest Hungary to commercialize and manufacture VT in Europe Latin America Australia Russia and other CIS countries VT an oral ant...

17

Oct 2019

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV

HitGen Inc today announced that it has entered into a drug discovery research collaboration with Galapagos NV to identify potential small molecule leads against targets of interest to Galapagos NV In this collaboration HitGen will apply its technology platform based on DNAencoded library design synt...

16

Oct 2019

WindMIL Therapeutics and University of California, Irvine Announce Collaboration to Collect Bone Marrow from Patients with Gliomas

WindMIL Therapeutics and the University of California Irvine UCI today announced that the first patients have been identified in an investigatorsponsored study for the collection of bone marrow from patients with gliomas The study will evaluate generating marrow infiltrating lymphocytes MILs for the...

16

Oct 2019

CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology

CRISPR Therapeutics a biopharmaceutical company focused on creating transformative genebased medicines for serious diseases and KSQ Therapeutics a biotechnology company using CRISPR technology to enable the companys powerful drug discovery engine to achieve higher probabilities of success in drug de...

15

Oct 2019

Novigenix and RadioMedix to Develop Neuroendocrine Cancer Precision Diagnostic Test

Novigenix SA a leading ImmunoTranscriptomics company that develops and commercializes solutions for early cancer detection and precision medicine today announced a collaboration agreement with RadioMedix Inc a radiopharmaceutical company to develop a precision diagnostic test based on Novigenixs tec...

press releasesRead more...

17

Oct 2019

Credence MedSystems Awarded Grant to Develop Its Dual Chamber Drug Delivery Device for the Global Health Setting

Credence MedSystems an innovator in injectable drug delivery technology for the biopharmaceutical industry announced today that it has been awarded a grant from the Bill Melinda Gates Foundation to support the development of Credences Dual Chamber Reconstitution Syringe tailored for use in developi...

17

Oct 2019

Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells

GammaDelta Therapeutics a company focussed on harnessing the unique properties of gamma delta Tcells to develop transformational immunotherapies today announced the formation of a spinout company Adaptate Biotherapeutics While GammaDelta Therapeutics primary goal is to develop Tcell based cell the...

16

Oct 2019

Replimune Provides Update on RP1 Clinical Development Program in Cutaneous Squamous Cell Carcinoma

Replimune Group Inc a biotechnology company developing oncolytic immunogene therapies derived from its Immulytic platform today announced that the first patient has been enrolled in its registrationdirected randomized controlled Phase clinical trial of RP in combination with Regeneron and Sanofis L...

16

Oct 2019

ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10

ProQR Therapeutics NV a company dedicated to changing lives through the creation of transformative RNA medicines for severe genetic rare diseases today announced that it received Rare Pediatric Disease RPD designation from the US Food and Drug Administration FDA for sepofarsen for the treatment of L...

15

Oct 2019

Ultragenyx Announces FDA Accepts New Drug Application for UX007 (triheptanoin) for Treatment of Long-chain Fatty Acid Oxidation Disorders

Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development of novel products for serious rare and ultrarare diseases today announced that the US Food and Drug Administration FDA has accepted for review the companys New Drug Application NDA for UX triheptanoin for the treatm...

EventsRead more...

17 - 19

Oct 2019

Excellence in Oncology Care (EIOC) 2019

Index Conferences & Exhibitions
Intercontinental Hotel, Festival City

17 - 18

Oct 2019

Clinical Trials Phase I & IIA Summit 2019

Sonesta Philadelphia Downtown Rittenhouse Square

18 - 18

Oct 2019

Health Outcomes Think Tank

Doubletree Hilton Metropolitan

20 - 24

Oct 2019

Emergency Medicine (WACEM)

Index Conferences & Exhibitions
Roda Al Bustan

Advertisements

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    Pharmaceutical Component Kinetics Inventory dynamic control is crucial

    Packaging Material PM components either primary secondary or tertiary are important for the medicinal product identity safety and stability despite they are not part of the dosage forms PM importance is evident from many recalls of drug products recorded in FDA database for various reasons such as mislabeling and contaminated materials

EDITORIAL SECTION

  • STRATEGY

    REDUCTION OF HEALTH COSTS

    Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...